BriaCell Therapeutics Corp. (BCTX) Amortizatization of Intangibles (2023 - 2026)

BriaCell Therapeutics has reported Amortizatization of Intangibles for 4 years, with the latest figure at $3817.0 in Q2 2026.

• Quarterly Amortizatization of Intangibles changed 0.0% year-over-year to $3817.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $15271.0 (changed 0.0% YoY) and the FY2025 annual result came in at $15271.0, changed 0.0% from the prior year.
• Amortizatization of Intangibles steadied at $3817.0 in Q2 2026 per BCTX's latest filing, from $3818.0 in the prior quarter.
• Over five years, Amortizatization of Intangibles peaked at $3818.0 in Q4 2023 and troughed at $3817.0 in Q2 2025.
• A 4-year average of $3817.8 and a median of $3818.0 in 2023 frame the typical range for Amortizatization of Intangibles.
• The widest YoY moves for Amortizatization of Intangibles: up 0.0% in 2024, down 0.0% in 2024.
• Over 4 years, Amortizatization of Intangibles stood at $3818.0 in 2023, then changed by 0.0% to $3818.0 in 2024, then changed by 0.0% to $3818.0 in 2025, then slipped by 0.03% to $3817.0 in 2026.
• According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $3817.0, $3818.0, and $3818.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.